|(C;C)||2||2x risk of autism reported by some (but not other) publications|
|(C;G)||1.6||1.6x increased autism risk|
However, since 2006, there have been several studies unable to replicate this association, as well as some replicating the finding, at least to varying degrees. These include:
- Those replicating to some degree the association with autism:
- Those finding no association of rs1858830 to autism:
[PMID 19002214] The association of rs1858830 in the MET gene with autism failed to replicate in 325 multiplex families and 10 trios of the International Molecular Genetic Study of Autism Consortium (IMGSAC), although another MET SNP did associate with autism (rs38845)
[PMID 19360663] Genetic evidence implicating multiple genes in the MET receptor tyrosine kinase pathway in autism spectrum disorder
[PMID 19681062] Further evidence that the rs1858830 C variant in the promoter region of the MET gene is associated with Autistic disorder
[PMID 22110649] Replication of the Association of a MET Variant with Autism in a Chinese Han Population
[PMID 19548256] Association of MET with social and communication phenotypes in individuals with autism spectrum disorder
[PMID 17696172] Disruption of cerebral cortex MET signaling in autism spectrum disorder.
[PMID 19255034] Distinct genetic risk based on association of MET in families with co-occurring autism and gastrointestinal conditions.
[PMID 20080979] Association of genetic variation in the MET proto-oncogene with schizophrenia and general cognitive ability.
[PMID 20615438] Further evidence for the role of MET in autism susceptibility.
|CLNSRC||OMIM Allelic Variant|